3,4-Dihydroxy-5-nitrobenzoic acid, 97%

Name: 3,4-Dihydroxy-5-nitrobenzoic acid, 97% | 84211-30-3
Brand: J&K Chemical
SKU: JK1832343_25_G
Price: 279.8 USD
Availability: OutOfStock

Cat. No JK1832343_25_G

Vendor: J&K Chemical

Product Information

Product Name

3,4-Dihydroxy-5-nitrobenzoic acid, 97%

Brand Name

J&K

Product Number

1832343

CAS

84211-30-3

Molecular Formula

C7H5NO6

Molecular Weight

199.12

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

14450982

IUPAC Name

3,4-dihydroxy-5-nitrobenzoic acid

InChI Key

HDPSONAKHMNQPA-UHFFFAOYSA-N

SMILES

C1=C(C=C(C(=C1N+(=O)O-)O)O)C(=O)O

References Data Source From Pubchem

PROTAC-based degradation of catechol-O-methyltransferase for potential treatment of Parkinson’s disease

Publication Name: Science China Chemistry

Publication Date: 2026-01-04

DOI: 10.1007/s11426-025-2982-3

Formation of nitrogen-containing gas phase products from the heterogeneous (photo)reaction of NO2 with gallic acid

Publication Name: Communications Chemistry

Publication Date: 2023-09-16

DOI: 10.1038/s42004-023-01003-3

Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile

Publication Name: European Journal of Drug Metabolism and Pharmacokinetics

Publication Date: 1994-06

DOI: 10.1007/bf03188833

Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog

Publication Name: European Journal of Drug Metabolism and Pharmacokinetics

Publication Date: 1993-12

DOI: 10.1007/bf03190186

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

Publication Name: Journal of Medicinal Chemistry

Publication Date: 1989-04

DOI: 10.1021/jm00124a017

3,4-Dihydroxy-5-nitrobenzoic acid, 97%

Product Information

General Information

References Data Source From Pubchem

PROTAC-based degradation of catechol-O-methyltransferase for potential treatment of Parkinson’s disease

Formation of nitrogen-containing gas phase products from the heterogeneous (photo)reaction of NO2 with gallic acid

Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile

Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors